High efficacy of eculizumab treatment for fulminant hemolytic anemia in primary cold agglutinin disease

Ann Hematol. 2019 Apr;98(4):1031-1032. doi: 10.1007/s00277-018-3521-4. Epub 2018 Oct 15.

Authors

Kenichi Makishima¹, Naoshi Obara², Kantaro Ishitsuka¹, Shinichiro Sukegawa¹, Sakurako Suma¹, Yusuke Kiyoki¹, Naoko Baba¹, Tatsuhiro Sakamoto¹, Takayasu Kato¹, Manabu Kusakabe¹, Hidekazu Nishikii¹, Naoki Kurita¹, Yasuhisa Yokoyama¹, Mamiko Sakata-Yanagimoto¹, Yuichi Hasegawa¹, Shigeru Chiba¹

Affiliations

¹ Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan.
² Department of Hematology, Faculty of Medicine, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki, 305-8575, Japan. n-obara@md.tsukuba.ac.jp.

PMID: 30324459
DOI: 10.1007/s00277-018-3521-4

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Adult
Anemia, Hemolytic, Autoimmune / blood*
Anemia, Hemolytic, Autoimmune / diagnosis*
Anemia, Hemolytic, Autoimmune / therapy*
Antibodies, Monoclonal, Humanized / administration & dosage*
Erythrocyte Transfusion*
Humans
Male

Substances

Antibodies, Monoclonal, Humanized
eculizumab